510(k) · Radiology

Ethos Treatment Management (3.0); Ethos Treatment Planning (2.0)

by Varian Medical Systems Inc.

Ethos Treatment Management (3.0); Ethos Treatment Planning (2.0) is an AI-enabled medical device from Varian Medical Systems Inc. that the U.S. FDA cleared through 510(k) K232923 on April 30, 2024. Its lead review panel is Radiology and its primary product code is IYE (Accelerator, Linear, Medical).

See also FDA-cleared AI radiology devices in 2024, all FDA AI clearances in 2024, top radiology AI devices.

Key facts

Submission numberK232923
Pathway510(k)
Date of final decision
Company (FDA list)Varian Medical Systems Inc.
Lead review panelRadiology
Primary product codeIYE — Accelerator, Linear, Medical
Applicant (openFDA)Varian Medical Systems, Inc.
Applicant locationPalo Alto, CA, US
Device classClass 2
Regulation number21 CFR 892.5050
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Ethos Treatment Management (3.0); Ethos Treatment Planning (2.0) went through this pathway (K232923).

openFDA lists it as a Class 2 device under 21 CFR 892.5050. Class II devices are moderate risk and are subject to general and special controls.

Product code IYE covers 3 devices on the FDA AI list. By decision date, this device is #2 of 3 under that code. Varian Medical Systems Inc. has 5 AI-enabled devices on the list, and the Radiology panel accounts for 1,230 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code IYE)

More from Varian Medical Systems Inc.